Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

- test

Small Protein Modification Can Trigger Invasive Properties of Prostate Cancer Cells, Research Finds

A small protein modification can trigger the aggressive migratory and invasive properties of prostate cancer cells, according to new research... Read More

Common Genetic Fusion Event Could Help Identify Patients with Low-Risk Prostate Cancer

Establishing the way in which a genetic alteration called a TMPRSS2-ERG gene fusion forms in a prostate cancer, rather than... Read More

UTSA Professor Awarded Grant to Support Development of Prostate Cancer Detection Method

Jing Yong Ye, professor of biomedical engineering at The University of Texas at San Antonio (UTSA), has received a two-year,... Read More

Fusion Guided Biopsy Can Help with Accurate Diagnosis of Prostate Cancer

There is a new technology available that can help with both predicting prostate cancer aggressiveness and detecting prostate cancer. It’s... Read More

New Diagnostic Test Uses Machine Learning to Accurately Detect Aggressive Prostate Cancer

A new diagnostic developed by Alberta scientists will allow men to bypass painful biopsies to test for aggressive prostate cancer.... Read More

Prolaris Becomes First Genetic Test to Receive Medicare Coverage for Favorable Intermediate and Low-Risk Prostate Cancer

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor... Read More

Addressing Unmet Needs in Prostate Cancer

An interview with Dr. Catherine Taylor, Therapy Area Lead Haematology, Janssen EMEA conducted by April Cashin-Garbutt, MA (Cantab) Read more.

Family History Does Not Appear to Increase Risk of Prostate Cancer Progression, Analysis Reveals

A recent analysis of the medical literature concluded that a family history of prostate cancer does not appear to increase... Read More

Novel Highly Potent SARDs May Offer Treatment Option for Advanced Prostate Cancer, Study Reports

Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer,... Read More

Vanderbilt Study Compares Side Effects, Outcomes of Prostate Cancer Treatments with Active Surveillance

Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want... Read More

1 2 3